BioXcel Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Mar 2026Filed 13/08/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 13/08/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/11/2025 | Mar 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0.2 | $0.2 | $0.1 | $0.1 | $0.2 | $0.2 | $1.1 | $0.6 | |
| −$15 | −$13 | −$31 | −$19 | −$7.3 | −$14 | −$8.3 | −$27 | |
| −$0.49 | −$0.54 | −$2.18 | −$2.45 | −$1.50 | −$5.15 | −$3.30 | −$13.89 | |
| 30 | 24 | 14 | 7.8 | 4.8 | 2.6 | 2.5 | 1.9 |
Trend